Transcription of Reference ID: 4110010 - VELCADE
{{id}} {{{paragraph}}}
Example: bachelor of science
Reference ID: 4110010 - VELCADE
1/38 HIGHLIGHTS OF prescribing information These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information for VELCADE . VELCADE ( bortezomib ) for injection, for subcutaneous or intravenous use Initial Approval: 2003 ------------------------RECENT MAJOR CHANGES------------------------- Warnings and Precautions ( ) 6/2017 ------------------------INDICATIONS AND USAGE-------------------------- VELCADE is a proteasome inhibitor indicated for: treatment of patients with multiple myeloma ( ) treatment of patients with mantle cell lymphoma ( ) ----------------------DOSAGE AND ADMINISTRATION--------------------- For subcutaneous or intravenous use only. Each route of administration has a different reconstituted concentration; Exercise caution when calculating the volume to be administered.
3/38 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE . 1.1 Multiple Myeloma . VELCADE ® (bortezomib) is indicated for the treatment of patients with multiple myeloma.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: